3
Announcements
Trials
Browse
Landscape
Status
Available
1
Sponsor Class
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Myeloid
2
Sarcoma
1
Plasma cell
1
Lymphoid
1
Gynecologic
1
Conditions
Sarcoma
9
Neurofibrosarcoma
4
Liposarcoma
3
Sarcoma, Alveolar Soft Part
2
Multiple Myeloma
2
Wilms Tumor
1
Vascular Neoplasms
1
Solitary Fibrous Tumors
1
Smooth Muscle Tumor
1
Sarcoma, Ewing
1
Sarcoma, Endometrial Stromal
1
Sarcoma, Clear Cell
1
Rhabdoid Tumor
1
Primary Myelofibrosis
1
Osteosarcoma
1
Nerve Sheath Neoplasms
1
Neoplasms, Adipose Tissue
1
Neoplasm Metastasis
1
Myoepithelioma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Large B-Cell, Diffuse
1
Liposarcoma, Myxoid
1
Leiomyosarcoma
1
Histiocytoma, Angiomatoid Fibrous
1
Hemangiosarcoma
1
Hemangioendothelioma, Epithelioid
1
Granuloma, Plasma Cell
1
Granular Cell Tumor
1
Glomus Tumor
1
Gliosarcoma
1
Interventions
Cyclophosphamide
19
fludarabine phosphate
17
Mycophenolic Acid
14
Antilymphocyte Serum
13
Peripheral Blood Stem Cell Transplantation
11
Cyclosporine
11
Tacrolimus
10
Filgrastim
10
Whole-Body Irradiation
9
Radiotherapy
8
Methotrexate
8
Busulfan
8
Methylprednisolone
7
Cord Blood Stem Cell Transplantation
7
Melphalan
6
Etoposide
5
sargramostim
3
Sirolimus
3
thymoglobulin
2
Prednisone
2
Polymerase Chain Reaction
2
Ondansetron
2
Itraconazole
2
Imatinib Mesylate
2
Granulocyte Colony-Stimulating Factor
2
Flow Cytometry
2
Early Intervention, Educational
2
Amplified Fragment Length Polymorphism Analysis
2
selinexor
1
merphos
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Primary Myelofibrosis
×
selinexor
×
Sarcoma
×
Clear all
NCT07215832
2026-03-02
KEAP
Karyopharm Therapeutics Inc
Available